BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29687323)

  • 1. Investigation of cis-4-[
    Verger A; Stoffels G; Galldiks N; Lohmann P; Willuweit A; Neumaier B; Geisler S; Langen KJ
    Mol Imaging Biol; 2018 Dec; 20(6):1035-1043. PubMed ID: 29687323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of remote neuronal reactions in the Thalamus and Hippocampus induced by rat glioma using the PET tracer cis-4-[¹⁸F]fluoro-D-proline.
    Geisler S; Willuweit A; Schroeter M; Zilles K; Hamacher K; Galldiks N; Shah NJ; Coenen HH; Langen KJ
    J Cereb Blood Flow Metab; 2013 May; 33(5):724-31. PubMed ID: 23385199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferred stereoselective transport of the D-isomer of cis-4-[18F]fluoro-proline at the blood-brain barrier.
    Langen KJ; Hamacher K; Bauer D; Bröer S; Pauleit D; Herzog H; Floeth F; Zilles K; Coenen HH
    J Cereb Blood Flow Metab; 2005 May; 25(5):607-16. PubMed ID: 15744252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of secondary thalamic degeneration after cortical infarction using cis-4-18F-fluoro-D-proline.
    Langen KJ; Salber D; Hamacher K; Stoffels G; Reifenberger G; Pauleit D; Coenen HH; Zilles K
    J Nucl Med; 2007 Sep; 48(9):1482-91. PubMed ID: 17704244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cis-4-[18F]fluoro-D-proline detects neurodegeneration in patients with akinetic-rigid parkinsonism.
    Sommerauer M; Galldiks N; Barbe MT; Stoffels G; Willuweit A; Coenen HH; Schroeter M; Timmermann L; Fink GR; Langen KJ
    Nucl Med Commun; 2019 Apr; 40(4):383-387. PubMed ID: 30875335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of gliomas with Cis-4-[18F]fluoro-L-proline.
    Langen KJ; Jarosch M; Hamacher K; Mühlensiepen H; Weber F; Floeth F; Pauleit D; Herzog H; Coenen HH
    Nucl Med Biol; 2004 Jan; 31(1):67-75. PubMed ID: 14741571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of cis- and trans-4-[(18)F]fluoro-L-proline in F98 glioma cells.
    Langen KJ; Mühlensiepen H; Schmieder S; Hamacher K; Bröer S; Börner AR; Schneeweiss FH; Coenen HH
    Nucl Med Biol; 2002 Aug; 29(6):685-92. PubMed ID: 12234594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment-Related Uptake of
    Geisler S; Stegmayr C; Niemitz N; Lohmann P; Rapp M; Stoffels G; Willuweit A; Galldiks N; Filss C; Sabel MC; Coenen HH; Shah NJ; Langen KJ
    J Nucl Med; 2019 Oct; 60(10):1373-1379. PubMed ID: 30850492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cis-4-[(18)F]-Fluoro-l-proline fails to detect peripheral tumors in humans.
    Stoffels G; Pauleit D; Haas R; Kobbe G; Salber D; Hamacher K; Coenen HH; Langen KJ
    Nucl Med Biol; 2008 Nov; 35(8):895-900. PubMed ID: 19026951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
    Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
    World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Dynamic O-(2-[
    Lohmann P; Piroth MD; Sellhaus B; Weis J; Geisler S; Oros-Peusquens AM; Mohlberg H; Amunts K; Shah NJ; Galldiks N; Langen KJ
    World Neurosurg; 2018 Nov; 119():e653-e660. PubMed ID: 30077752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flare Phenomenon in
    Filss CP; Schmitz AK; Stoffels G; Stegmayr C; Lohmann P; Werner JM; Sabel M; Rapp M; Goldbrunner R; Neumaier B; Mottaghy FM; Shah NJ; Fink GR; Galldiks N; Langen KJ
    J Nucl Med; 2020 Sep; 61(9):1294-1299. PubMed ID: 32005771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of O-(2-[18F]fluoroethyl)-L-tyrosine in reactive astrocytosis in the vicinity of cerebral gliomas.
    Piroth MD; Prasath J; Willuweit A; Stoffels G; Sellhaus B; van Osterhout A; Geisler S; Shah NJ; Eble MJ; Coenen HH; Langen KJ
    Nucl Med Biol; 2013 Aug; 40(6):795-800. PubMed ID: 23769262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis.
    Galldiks N; Stoffels G; Filss CP; Piroth MD; Sabel M; Ruge MI; Herzog H; Shah NJ; Fink GR; Coenen HH; Langen KJ
    J Nucl Med; 2012 Sep; 53(9):1367-74. PubMed ID: 22872742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
    Lapa C; Linsenmann T; Monoranu CM; Samnick S; Buck AK; Bluemel C; Czernin J; Kessler AF; Homola GA; Ernestus RI; Löhr M; Herrmann K
    J Nucl Med; 2014 Oct; 55(10):1611-6. PubMed ID: 25125481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma.
    Rapp M; Heinzel A; Galldiks N; Stoffels G; Felsberg J; Ewelt C; Sabel M; Steiger HJ; Reifenberger G; Beez T; Coenen HH; Floeth FW; Langen KJ
    J Nucl Med; 2013 Feb; 54(2):229-35. PubMed ID: 23232275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?
    Pöpperl G; Kreth FW; Herms J; Koch W; Mehrkens JH; Gildehaus FJ; Kretzschmar HA; Tonn JC; Tatsch K
    J Nucl Med; 2006 Mar; 47(3):393-403. PubMed ID: 16513607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
    Pauleit D; Stoffels G; Bachofner A; Floeth FW; Sabel M; Herzog H; Tellmann L; Jansen P; Reifenberger G; Hamacher K; Coenen HH; Langen KJ
    Nucl Med Biol; 2009 Oct; 36(7):779-87. PubMed ID: 19720290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of O-(2-
    Verger A; Filss CP; Lohmann P; Stoffels G; Sabel M; Wittsack HJ; Kops ER; Galldiks N; Fink GR; Shah NJ; Langen KJ
    World Neurosurg; 2018 May; 113():e727-e737. PubMed ID: 29510293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.